Buyer Name: CARDIFF UNIVERSITY
Buyer Address: Park Place, Cardiff, UKL22, CF10 3AT, United Kingdom
Contact Email: procurement@cardiff.ac.uk
Buyer Name: CARDIFF UNIVERSITY
Buyer Address: Park Place, Cardiff, UKL22, CF10 3AT, United Kingdom
Contact Email: procurement@cardiff.ac.uk
T1D-Plus trial is a randomised, adaptive, open label, parallel group, multi-centre Platform trial in adults with newly diagnosed type 1 diabetes). The T1D Plus trial, funded by JDRF, sponsored by CU, started on 30th September 2022, led by Colin Dayan. Since that time, additional arms of the trial have been funded by separate grants from the Helmsley Charitable Trust and JDRF Australia. Funding was agreed in Dec 2023. An endpoint in the trial is the recording of glucose levels by a continuous glucose monitoring device. These devices are marketed by different companies with different specifications.
Lot 1 Status: complete
Contract Title: T1D-Plus study with Dexcom
{
"awards": [
{
"id": "1",
"items": [
{
"additionalClassifications": [
{
"description": "Data-processing machines (hardware)",
"id": "30210000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"country": "GB",
"countryName": "United Kingdom",
"region": "UK"
}
],
"id": "1",
"relatedLot": "1"
}
],
"mainProcurementCategory": "goods",
"relatedLots": [
"1"
],
"status": "active",
"suppliers": [
{
"id": "GB-FTS-171813",
"name": "Dexcom International Limited"
}
]
}
],
"buyer": {
"id": "GB-COH-RC000089",
"name": "CARDIFF UNIVERSITY"
},
"contracts": [
{
"aboveThreshold": false,
"awardID": "1",
"dateSigned": "2026-01-19T00:00:00Z",
"documents": [
{
"documentType": "contractSigned",
"format": "application/vnd.openxmlformats-officedocument.wordprocessingml.document",
"id": "A-10460",
"url": "https://www.find-tender.service.gov.uk/Notice/Attachment/A-10460"
},
{
"datePublished": "2026-01-19T12:26:03Z",
"description": "Contract details notice on Find a Tender",
"documentType": "contractNotice",
"format": "text/html",
"id": "004306-2026",
"noticeType": "UK7",
"url": "https://www.find-tender.service.gov.uk/Notice/004306-2026"
}
],
"id": "1",
"period": {
"endDate": "2027-01-20T23:59:59Z",
"startDate": "2026-01-20T00:00:00Z"
},
"status": "active",
"title": "T1D-Plus study with Dexcom",
"value": {
"amount": 76000,
"amountGross": 91200,
"currency": "GBP"
}
}
],
"date": "2026-01-19T12:26:03Z",
"id": "004306-2026",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-060896",
"parties": [
{
"additionalIdentifiers": [
{
"id": "PHVT-4343-HWYR",
"scheme": "GB-PPON"
}
],
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Cardiff",
"postalCode": "CF10 3AT",
"region": "UKL22",
"streetAddress": "Park Place"
},
"contactPoint": {
"email": "procurement@cardiff.ac.uk"
},
"details": {
"classifications": [
{
"description": "Public authority - sub-central government",
"id": "publicAuthoritySubCentralGovernment",
"scheme": "UK_CA_TYPE"
},
{
"description": "Welsh devolved regulations apply",
"id": "GB-WLS",
"scheme": "UK_CA_DEVOLVED_REGULATIONS"
}
],
"url": "http://www.cardiff.ac.uk"
},
"id": "GB-COH-RC000089",
"identifier": {
"id": "RC000089",
"scheme": "GB-COH"
},
"name": "CARDIFF UNIVERSITY",
"roles": [
"buyer"
]
},
{
"address": {
"country": "GB",
"countryName": "United Kingdom",
"locality": "Edinburgh",
"postalCode": "EH3 5DA",
"region": "UKM75",
"streetAddress": "1 Tanfield"
},
"contactPoint": {
"email": "sian.rilstone@dexcom.com"
},
"details": {
"scale": "large",
"vcse": false
},
"id": "GB-FTS-171813",
"name": "Dexcom International Limited",
"roles": [
"supplier"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"description": "T1D-Plus trial is a randomised, adaptive, open label, parallel group, multi-centre Platform trial in adults with newly diagnosed type 1 diabetes). The T1D Plus trial, funded by JDRF, sponsored by CU, started on 30th September 2022, led by Colin Dayan. Since that time, additional arms of the trial have been funded by separate grants from the Helmsley Charitable Trust and JDRF Australia. Funding was agreed in Dec 2023. \nAn endpoint in the trial is the recording of glucose levels by a continuous glucose monitoring device. These devices are marketed by different companies with different specifications.",
"id": "CU.1863.HM",
"legalBasis": {
"id": "2023/54",
"scheme": "UKPGA",
"uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
},
"lots": [
{
"id": "1",
"status": "complete"
}
],
"procurementMethod": "direct",
"procurementMethodDetails": "Below threshold - without competition",
"status": "complete",
"title": "T1D-Plus study with Dexcom"
}
}